跳至主要内容
临床试验/ITMCTR2200006006
ITMCTR2200006006尚未招募1 期

Clinical study on efficacy and safety of Huangqi Guizhi Wuwu decoction bubble bag in paclitaxel related peripheral neuritis of breast cancer patients : A protocol for a randomized, controlled, double-blind trial

ational Cancer Center, Chinese Academy of Medical Sciences / Cancer Hospital of Peking Union Medical College0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 80(—)
性别
All

入选标准

  • ????????????????;???18-70?;???????????????????:????????,?????,??????,??????;???????3????;?????????????;???????,???????
  • ????????????????;???18-70?;???????????????????:????????,?????,??????,??????;???????3????;?????????????;???????,???????
  • (1) breast cancer patients confirmed by histology or pathology; ? Age 18-70 years old; ? Plan to receive or have received paclitaxel drugs: including solvent paclitaxel, docetaxel, albumin paclitaxel, paclitaxel liposome; ? The estimated survival time is more than 3 months; ? It conforms to the category of syndrome differentiation and treatment of blood arthralgia in traditional Chinese medicine; The patient is unconscious and can communicate with normal language

排除标准

  • ? Age < 18 years old, > 70 years old; ? Peripheral neuropathy caused by other reasons; ? There are heart, liver and kidney insufficiency, cardiovascular disease and endocrine disease; Accompanied by mental and consciousness disorders; Severe skin disease and systemic infection; ? The patient was involuntary.

研究者

发起方
ational Cancer Center, Chinese Academy of Medical Sciences / Cancer Hospital of Peking Union Medical College

相似试验